Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains

Antimicrob Agents Chemother. 1993 Sep;37(9):2030-2. doi: 10.1128/AAC.37.9.2030.

Abstract

Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C. parapsilosis. Rabbits received no therapy, amphotericin B (1 mg/kg of body weight per day intravenously), or fluconazole (100 mg/kg/day intraperitoneally) for either 11 or 21 days. Against both species, amphotericin B and fluconazole were equally effective overall; however, amphotericin B was more rapidly fungicidal than fluconazole in vivo against C. tropicalis.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / administration & dosage
  • Amphotericin B / pharmacology
  • Amphotericin B / therapeutic use*
  • Animals
  • Candida / drug effects
  • Candidiasis / drug therapy*
  • Candidiasis / microbiology
  • Endocarditis / drug therapy*
  • Endocarditis / microbiology
  • Female
  • Fluconazole / administration & dosage
  • Fluconazole / pharmacology
  • Fluconazole / therapeutic use*
  • Heart / microbiology
  • Injections, Intravenous
  • Microbial Sensitivity Tests
  • Rabbits

Substances

  • Amphotericin B
  • Fluconazole